ShapeTX


Shape Therapeutics is a biotechnology company developing next-generation RNA-targeted therapies to treat the world’s most challenging diseases.

Employees

51-200

Links


Org chart

Adrian W Briggs
VP, Head of Platform Technologies
Ken Prentice
VP, Head of Process and Product Development
Collin H.
Director, Cell & Vector Engineering
Marsha Mason
Associate Director, Program and Portfolio Management
Stephanie Blij
Vice President, Head Of Legal
Ron Hause
VP, Head of Analytics and Informatics